184 related articles for article (PubMed ID: 11564827)
1. Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.
Salih HR; Schmetzer HM; Burke C; Starling GC; Dunn R; Pelka-Fleischer R; Nuessler V; Kiener PA
J Immunol; 2001 Oct; 167(7):4059-66. PubMed ID: 11564827
[TBL] [Abstract][Full Text] [Related]
2. A functional anti-human 4-1BB ligand monoclonal antibody that enhances proliferation of monocytes by reverse signaling of 4-1BBL.
Ju SW; Ju SG; Wang FM; Gu ZJ; Qiu YH; Yu GH; Ma HB; Zhang XG
Hybrid Hybridomics; 2003 Oct; 22(5):333-8. PubMed ID: 14678652
[TBL] [Abstract][Full Text] [Related]
3. Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.
Salih HR; Kosowski SG; Haluska VF; Starling GC; Loo DT; Lee F; Aruffo AA; Trail PA; Kiener PA
J Immunol; 2000 Sep; 165(5):2903-10. PubMed ID: 10946324
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.
Futagawa T; Akiba H; Kodama T; Takeda K; Hosoda Y; Yagita H; Okumura K
Int Immunol; 2002 Mar; 14(3):275-86. PubMed ID: 11867564
[TBL] [Abstract][Full Text] [Related]
5. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB.
Loo DT; Chalupny NJ; Bajorath J; Shuford WW; Mittler RS; Aruffo A
J Biol Chem; 1997 Mar; 272(10):6448-56. PubMed ID: 9045669
[TBL] [Abstract][Full Text] [Related]
7. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
[TBL] [Abstract][Full Text] [Related]
8. Activation of c-jun N-terminal kinase by 4-1BB (CD137), a T cell co-stimulatory molecule.
Kim HH; Kwack K; Lee ZH
Mol Cells; 2000 Jun; 10(3):247-52. PubMed ID: 10901161
[TBL] [Abstract][Full Text] [Related]
9. Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.
Liu GZ; Gomes AC; Putheti P; Karrenbauer V; Kostulas K; Press R; Hillert J; Hjelmström P; Gao XG
Scand J Immunol; 2006 Oct; 64(4):412-9. PubMed ID: 16970683
[TBL] [Abstract][Full Text] [Related]
10. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cheuk AT; Mufti GJ; Guinn BA
Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
[TBL] [Abstract][Full Text] [Related]
11. Costimulation of CD28- T lymphocytes by 4-1BB ligand.
DeBenedette MA; Shahinian A; Mak TW; Watts TH
J Immunol; 1997 Jan; 158(2):551-9. PubMed ID: 8992967
[TBL] [Abstract][Full Text] [Related]
12. Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity.
Rabu C; Quéméner A; Jacques Y; Echasserieau K; Vusio P; Lang F
J Biol Chem; 2005 Dec; 280(50):41472-81. PubMed ID: 16204238
[TBL] [Abstract][Full Text] [Related]
13. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
14. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
[TBL] [Abstract][Full Text] [Related]
15. Differential clonal expansion of CD4 and CD8 T cells in response to 4-1BB ligation: contribution of 4-1BB during inflammatory responses.
Takahashi C; Mittler RS; Vella AT
Immunol Lett; 2001 Apr; 76(3):183-91. PubMed ID: 11306146
[TBL] [Abstract][Full Text] [Related]
16. A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity.
Yoshida H; Katayose Y; Unno M; Suzuki M; Kodama H; Takemura S; Asano R; Hayashi H; Yamamoto K; Matsuno S; Kudo T
Cancer Immunol Immunother; 2003 Feb; 52(2):97-106. PubMed ID: 12594573
[TBL] [Abstract][Full Text] [Related]
17. Progressive depletion of peripheral B lymphocytes in 4-1BB (CD137) ligand/I-Ealpha)-transgenic mice.
Zhu G; Flies DB; Tamada K; Sun Y; Rodriguez M; Fu YX; Chen L
J Immunol; 2001 Sep; 167(5):2671-6. PubMed ID: 11509610
[TBL] [Abstract][Full Text] [Related]
18. Role of 4-1BB in immune responses.
Vinay DS; Kwon BS
Semin Immunol; 1998 Dec; 10(6):481-9. PubMed ID: 9826581
[TBL] [Abstract][Full Text] [Related]
19. 4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniae.
Wu ZQ; Khan AQ; Shen Y; Wolcott KM; Dawicki W; Watts TH; Mittler RS; Snapper CM
Infect Immun; 2003 Jan; 71(1):196-204. PubMed ID: 12496166
[TBL] [Abstract][Full Text] [Related]
20. CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival.
Palma C; Binaschi M; Bigioni M; Maggi CA; Goso C
Int J Cancer; 2004 Jan; 108(3):390-8. PubMed ID: 14648705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
